Stay updated on SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A site-wide notice about NIH’s terminology transition was added, and the site revision changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:49:48.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-06T22:45:47.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error screen in place of the study details, indicating an access issue. The added 403 header and text contrast with the removal of typical study metadata, showing that the page content is not currently retrievable rather than a content update.
    Difference
    22%
    Check dated 2026-09-22T23:06:28.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now displays a Study status section and the revision label was updated from v3.6.6 to v3.7.0, replacing the previous Status label.
    Difference
    0.1%
    Check dated 2026-09-15T21:01:37.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.6.6 has been introduced, replacing the previous v3.6.5. This change indicates a minor version update with no visible changes to the page content or user experience.
    Difference
    0.0%
    Check dated 2026-09-01T18:11:56.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    A new line was added under Other Study ID Numbers: 2018(U.S. NIH Grant/Contract), indicating a funding source for the study.
    Difference
    0.0%
    Check dated 2026-08-25T16:41:15.000Z thumbnail image

Stay in the know with updates to SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial page.